Replies to post #705 on NRX Pharmaceuticals Inc (NRXP)

[Joe Kaplan]

Looking pretty grim today for NRX. New lows again.

Short of a quick and compete settlement with RLF, and quick approval
by the FDA for AVIPTADIL / ZYESAMI, it looks like NRX is in for
some heavy stormy hurricane weather.

Perhaps Brilife can manage a big win to NRX and a miraculous come back for NRX stock price. It continues down, even at this level.

Those days of double digit prices sure look long gone now.

[Joe Kaplan]

Lawsuits are Turning into Get in Line and take a number..
Now Another.... Robbins Geller Rudman & Dowd

https://www.bloomberg.com/press-releases/2022-01-20/alert-nrx-pharmaceuticals-inc-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-nrxp-nrxpw


https://www.lawyer-monthly.com/2022/01/alert-nrx-pharmaceuticals-inc-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-nrxp-nrxpw/

Gotta wonder if DENIAL is the main defense here also.
So far not a word from the company.